Answers are grounded in this paper and cite their sources.
Parkinson's Disease (PD) is an irreversible degenerative neurological disorder with no known cure. Apomorphine is a potent short-acting D1/D2 dopamine agonist administered sub-cutaneously that is used in the treatment of PD. Optimising PD medication is an important aspect of end of life care. There are no previously reported cases of apomorphine providing symptom relief in terminal care of PD patients. This case highlights its potential benefits for symptom control at the end of life.
No takes yet. Share an insight, caveat, or question.
Dewhurst et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: